Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |